Business

LAB/B: Sales declined due to hyperinflation and weak demand, but margins and cost controls remained strong

Genomma Lab Internacional Sab De Cv Class BOctober 23, 20255

About this update from Genomma Lab Internacional Sab De Cv Class B

Like-for-like sales fell 2.9% and net sales dropped 12.8% year-over-year, mainly due to hyperinflationary effects in Argentina and weak demand in Mexico, but EBITDA margin held at 23.7%. Productivity initiatives and cost controls supported resilience, with growth expected to resume in 1H 2026. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Genomma Lab Internacional Sab De Cv Class B

LAB/B: Sales declined due to hyperinflation and weak demand, but margins and cost controls remained strong

About this update from Genomma Lab Internacional Sab De Cv Class B

More from Genomma Lab Internacional Sab De Cv Class B

LAB/B: Net sales fell 4.9% as FX and weak demand weighed, but LATAM growth and margin gains offset declines

LAB/B: Margins held strong despite sales decline, with recovery and growth initiatives set for 2026